Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasculopathic Injury and Plasma as Endothelial Rescue – OCTAplas trial
2014-000452-28Phase 4Completed
- Sponsor
- Capitol Region Blood Bank
- Start
- Sep 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of octaplas lg in thoracic aortic dissection (TAD), clotting factor deficiency and endothelial dysfunction (2 arms), sponsored by Capitol Region Blood Bank. Primary endpoint: Plasma levels of endothelial markers. Started Sep 2014; status: completed.
02
Drugs
octaplas lg
03
Conditions
thoracic aortic dissection (TAD)clotting factor deficiencyendothelial dysfunction
Beyond the preview
Go deeper on 2014-000452-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000452-28.